Suppr超能文献

CYLD基因缺失会触发核因子-κB信号通路,并增强小鼠肝细胞的抗细胞死亡能力。

CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes.

作者信息

Urbanik Toni, Koehler Bruno Christian, Wolpert Laura, Elßner Christin, Scherr Anna-Lena, Longerich Thomas, Kautz Nicole, Welte Stefan, Hövelmeyer Nadine, Jäger Dirk, Waisman Ari, Schulze-Bergkamen Henning

机构信息

Toni Urbanik, Bruno Christian Koehler, Laura Wolpert, Christin Elßner, Anna-Lena Scherr, Nicole Kautz, Stefan Welte, Dirk Jäger, Henning Schulze-Bergkamen, National Center for Tumor Diseases, Department of Medical Oncology, University Clinic of Heidelberg, 69120 Heidelberg, Baden-Wuerrtemberg, Germany.

出版信息

World J Gastroenterol. 2014 Dec 7;20(45):17049-64. doi: 10.3748/wjg.v20.i45.17049.

Abstract

AIM

To analyze the role of CYLD for receptor-mediated cell death of murine hepatocytes in acute liver injury models.

METHODS

Hepatocyte cell death in CYLD knockout mice (CYLD(-/-) ) was analyzed by application of liver injury models for CD95- (Jo2) and tumor necrosis factor (TNF)-α- [D-GalN/lipopolysaccharide (LPS)] induced apoptosis. Liver injury was assessed by measurement of serum transaminases and histological analysis. Apoptosis induction was quantified by cleaved PARP staining and Western blotting of activated caspases. Nuclear factor (NF)-κB, ERK, Akt and jun amino-terminal kinases signaling were assessed. Primary Hepatocytes were isolated by two step-collagenase perfusion and treated with recombinant TNF-α and with the CD95-ligand Jo2. Cell viability was analyzed by MTT-assay.

RESULTS

Livers of CYLD(-/-) mice showed increased anti-apoptotic NF-κB signaling. In both applied liver injury models CYLD(-/-) mice showed a significantly reduced apoptosis sensitivity. After D-GalN/LPS treatment CYLD(-/-) mice exhibited significantly lower levels of alanine aminotransferase (ALT) (295 U/L vs 859 U/L, P < 0.05) and aspartate aminotransferase (AST) (560 U/L vs 1025 U/L, P < 0.01). After Jo injection CYLD(-/-) mice showed 2-fold lower ALT (50 U/L vs 110 U/L, P < 0.01) and lower AST (250 U/L vs 435 U/L, P < 0.01) serum-levels compared to WT mice. In addition, isolated CYLD(-/-) primary murine hepatocytes (PMH) were less sensitive towards death receptor-mediated apoptosis and showed increased levels of Bcl-2, XIAP, cIAP1/2, survivin and c-FLIP expression upon TNF- and CD95-receptor triggering, respectively. Inhibition of NF-κB activation by the inhibitor of NF-κB phosphorylation inhibitor BAY 11-7085 inhibited the expression of anti-apoptotic proteins and re-sensitized CYLD(-/-) PMH towards TNF- and CD95-receptor mediated cell death.

CONCLUSION

CYLD is a central regulator of apoptotic cell death in murine hepatocytes by controlling NF-κB dependent anti-apoptotic signaling.

摘要

目的

分析CYLD在急性肝损伤模型中对小鼠肝细胞受体介导的细胞死亡的作用。

方法

通过应用针对CD95(Jo2)和肿瘤坏死因子(TNF)-α[D-半乳糖胺/脂多糖(LPS)]诱导的凋亡的肝损伤模型,分析CYLD基因敲除小鼠(CYLD(-/-))中的肝细胞死亡情况。通过测量血清转氨酶和组织学分析评估肝损伤。通过裂解的PARP染色和活化的半胱天冬酶的蛋白质印迹法定量凋亡诱导。评估核因子(NF)-κB、细胞外信号调节激酶(ERK)、蛋白激酶B(Akt)和c-Jun氨基末端激酶信号传导。通过两步胶原酶灌注分离原代肝细胞,并用重组TNF-α和CD95配体Jo2处理。通过MTT法分析细胞活力。

结果

CYLD(-/-)小鼠的肝脏显示抗凋亡NF-κB信号增强。在两种应用的肝损伤模型中,CYLD(-/-)小鼠的凋亡敏感性均显著降低。在D-半乳糖胺/LPS处理后,CYLD(-/-)小鼠的丙氨酸转氨酶(ALT)水平(295 U/L对859 U/L,P < 0.05)和天冬氨酸转氨酶(AST)水平(560 U/L对1025 U/L,P < 0.01)显著更低。在注射Jo后,与野生型小鼠相比,CYLD(-/-)小鼠的ALT血清水平降低了2倍(50 U/L对110 U/L,P < 0.01),AST血清水平更低(250 U/L对435 U/L,P < 0.01)。此外,分离的CYLD(-/-)原代小鼠肝细胞(PMH)对死亡受体介导的凋亡敏感性较低,并且在TNF和CD95受体触发后,分别显示Bcl-2、X连锁凋亡抑制蛋白(XIAP)、细胞凋亡抑制蛋白1/2(cIAP1/2)、生存素和细胞凋亡抑制蛋白(c-FLIP)表达水平升高。通过NF-κB磷酸化抑制剂BAY 11-7085抑制NF-κB激活,抑制了抗凋亡蛋白的表达,并使CYLD(-/-) PMH对TNF和CD95受体介导的细胞死亡重新敏感。

结论

CYLD通过控制NF-κB依赖性抗凋亡信号传导,是小鼠肝细胞凋亡性细胞死亡的中心调节因子。

相似文献

1
CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes.
World J Gastroenterol. 2014 Dec 7;20(45):17049-64. doi: 10.3748/wjg.v20.i45.17049.
4
Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
World J Gastroenterol. 2015 Sep 28;21(36):10375-84. doi: 10.3748/wjg.v21.i36.10375.
6
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.
J Hepatol. 2011 Dec;55(6):1272-80. doi: 10.1016/j.jhep.2011.03.008. Epub 2011 Apr 15.
8
Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
Chem Biol Interact. 2010 Dec 5;188(3):526-34. doi: 10.1016/j.cbi.2010.09.008. Epub 2010 Sep 17.
10
Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
Eur J Pharmacol. 2010 Jun 10;635(1-3):188-93. doi: 10.1016/j.ejphar.2010.03.007. Epub 2010 Mar 19.

引用本文的文献

1
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency.
Cancers (Basel). 2023 Oct 15;15(20):4997. doi: 10.3390/cancers15204997.
2
YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling.
Appl Biochem Biotechnol. 2024 Jan;196(1):588-603. doi: 10.1007/s12010-023-04540-8. Epub 2023 May 10.
3
Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology.
J Cell Biochem. 2022 Oct;123(10):1634-1646. doi: 10.1002/jcb.30312. Epub 2022 Aug 4.
4
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure.
Cell Death Dis. 2022 May 31;13(5):510. doi: 10.1038/s41419-022-04946-y.
5
The Functional Role of Long Non-Coding RNAs in Melanoma.
Cancers (Basel). 2021 Sep 28;13(19):4848. doi: 10.3390/cancers13194848.
6
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells.
Genes Environ. 2021 Jun 7;43(1):21. doi: 10.1186/s41021-021-00192-4.
7
The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
RNA Biol. 2020 Nov;17(11):1576-1589. doi: 10.1080/15476286.2019.1709296. Epub 2020 Jan 7.
8
9
CYLD Deubiquitinase Negatively Regulates High Glucose-Induced NF-B Inflammatory Signaling in Mesangial Cells.
Biomed Res Int. 2017;2017:3982906. doi: 10.1155/2017/3982906. Epub 2017 Nov 12.

本文引用的文献

1
Treat cancers by targeting survivin: just a dream or future reality?
Cancer Treat Rev. 2013 Nov;39(7):802-11. doi: 10.1016/j.ctrv.2013.02.002. Epub 2013 Feb 28.
2
Role of β-Catenin in regulating the balance between TNF-α- and Fas-induced acute liver injury.
Cancer Lett. 2013 Jul 10;335(1):160-7. doi: 10.1016/j.canlet.2013.02.008. Epub 2013 Feb 11.
3
A Systems Biology Study on NFκB Signaling in Primary Mouse Hepatocytes.
Front Physiol. 2012 Dec 31;3:466. doi: 10.3389/fphys.2012.00466. eCollection 2012.
4
The proteasome in health and disease.
Curr Pharm Des. 2013;19(6):1010-28.
5
CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.
J Invest Dermatol. 2013 Jan;133(1):221-9. doi: 10.1038/jid.2012.253. Epub 2012 Jul 26.
6
Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.
J Hepatol. 2012 Nov;57(5):995-1003. doi: 10.1016/j.jhep.2012.06.017. Epub 2012 Jun 21.
9
CYLD: a deubiquitination enzyme with multiple roles in cancer.
Future Oncol. 2011 Feb;7(2):285-97. doi: 10.2217/fon.10.187.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验